Evidence map›Paper›PMID 35776712›Full record

ArticlePLoS computational biology2022

A structured model and likelihood approach to estimate yeast prion propagon replication rates and their asymmetric transmission.

Fabian Santiago, Suzanne Sindi

Abstract read
In one paragraph

Article in PLoS computational biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Fabian SantiagoDepartment of Mathematics, University of Arizona, Tucson, Arizona, United States of America.ORCID 0000-0002-5369-4128
Suzanne SindiDepartment of Applied Mathematics, University of California Merced, Merced, California, United States of America.ORCID 0000-0003-2742-4332

Funding

Mathematical Strategies to Uncover the Molecular Basis of Prion Transitions R01GM126548 · NIGMS · UNIVERSITY OF CALIFORNIA, MERCED · PI SINDI, SUZANNE · 2017 to 2020
$854k
NIGMS NIH HHS R01 GM126548
6 · The paper itself

Abstract

Prion proteins cause a variety of fatal neurodegenerative diseases in mammals but are generally harmless to Baker's yeast (Saccharomyces cerevisiae). This makes yeast an ideal model organism for investigating the protein dynamics associated with these diseases. The rate of disease onset is related to both the replication and transmission kinetics of propagons, the transmissible agents of prion diseases. Determining the kinetic parameters of propagon replication in yeast is complicated because the number of propagons in an individual cell depends on the intracellular replication dynamics and the asymmetric division of yeast cells within a growing yeast cell colony. We present a structured population model describing the distribution and replication of prion propagons in an actively dividing population of yeast cells. We then develop a likelihood approach for estimating the propagon replication rate and their transmission bias during cell division. We first demonstrate our ability to correctly recover known kinetic parameters from simulated data, then we apply our likelihood approach to estimate the kinetic parameters for six yeast prion variants using propagon recovery data. We find that, under our modeling framework, all variants are best described by a model with an asymmetric transmission bias. This demonstrates the strength of our framework over previous formulations assuming equal partitioning of intracellular constituents during cell division.

Indexed as

PrionsSaccharomyces cerevisiae ProteinsAnimalsLikelihood FunctionsMammalsPrion ProteinsSaccharomyces cerevisiaePrion ProteinsPrionsSaccharomyces cerevisiae Proteins

Identifiers

PMID35776712
PMCPMC9249220

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.